- Home
- MLCI vs BYSI Comparison
MLCI vs BYSI Comparison
Compare MLCI & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLCI
- BYSI
- Stock Information
- Founded
- MLCI N/A
- BYSI 2010
- Country
- MLCI United States
- BYSI United States
- Employees
- MLCI N/A
- BYSI N/A
- Industry
- MLCI Investment Managers
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- MLCI Finance
- BYSI Health Care
- Exchange
- MLCI Nasdaq
- BYSI Nasdaq
- Market Cap
- MLCI 98.0M
- BYSI 79.0M
- IPO Year
- MLCI N/A
- BYSI 2017
- Fundamental
- Price
- MLCI $7.77
- BYSI $1.87
- Analyst Decision
- MLCI
- BYSI
- Analyst Count
- MLCI 0
- BYSI 0
- Target Price
- MLCI N/A
- BYSI N/A
- AVG Volume (30 Days)
- MLCI 37.7K
- BYSI 24.5K
- Earning Date
- MLCI 01-01-0001
- BYSI 11-12-2025
- Dividend Yield
- MLCI 3.10%
- BYSI N/A
- EPS Growth
- MLCI N/A
- BYSI N/A
- EPS
- MLCI N/A
- BYSI N/A
- Revenue
- MLCI $99,281,000.00
- BYSI N/A
- Revenue This Year
- MLCI N/A
- BYSI N/A
- Revenue Next Year
- MLCI N/A
- BYSI N/A
- P/E Ratio
- MLCI N/A
- BYSI N/A
- Revenue Growth
- MLCI N/A
- BYSI N/A
- 52 Week Low
- MLCI $7.15
- BYSI $0.98
- 52 Week High
- MLCI $8.75
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- MLCI N/A
- BYSI 41.37
- Support Level
- MLCI N/A
- BYSI $1.86
- Resistance Level
- MLCI N/A
- BYSI $2.17
- Average True Range (ATR)
- MLCI 0.00
- BYSI 0.18
- MACD
- MLCI 0.00
- BYSI -0.02
- Stochastic Oscillator
- MLCI 0.00
- BYSI 0.00
About MLCI Mount Logan Capital Inc. Common Stock
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.